TheraNovex AI Agent Generates Complete Clinical Trial Marketing Campaigns in 10 Minutes

San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of its Study Ad Materials AI Agent. This first-of-its-kind AI Creative Studio eliminates the traditional weeks-long process of creating recruitment marketing materials, allowing research sites and sponsors to generate complete, IRB-compliant multi-channel campaigns in just 10 minutes.

By simply inputting a study’s inclusion and exclusion criteria, the TheraNovex AI Agent produces a comprehensive marketing toolkit that previously required a full team of graphic designers, copywriters, compliance reviewers, and audio production studios. The platform marks a significant shift in clinical trial operations, reducing marketing production time by 90% and saving sponsors between $5,000 and $15,000 in creative costs per study.

Key Features of the AI Creative Studio

IRB-Compliant Flyers: Automatically generates professional layouts with study-appropriate imagery, required regulatory disclaimers, and clear calls-to-action in multiple print and digital formats.
Platform-Specific Ad Copy: Creates optimized headlines and descriptions for Google Ads, Facebook, Instagram, Twitter/X, and LinkedIn, ensuring compliance with each platform's specific healthcare advertising policies.
Custom Graphics & Social Assets: Produces high-resolution visual assets tailored to different social media dimensions, including Instagram Stories and Google Display ads.
Patient Screening Scripts: Develops conversational scripts for coordinators that convert complex clinical criteria into easy-to-understand questions with built-in skip logic.
Broadcast-Ready Radio Commercials: Generates professional audio spots (15, 30, and 60 seconds) featuring human-quality AI voice talent and royalty-free background music matched to the study's therapeutic area.

How It Works: From Criteria to Campaign in 10 Minutes

The TheraNovex Study Ad Materials AI Agent replaces a traditional 2-to-4-week production cycle with a streamlined three-step automated workflow:

Step 1: Input Study Criteria (2 minutes) – The user enters the study title, therapeutic area, and copies/pastes the inclusion and exclusion criteria directly from the protocol. Users can also select target demographics such as age, gender, and location.

Step 2: Automated AI Generation (5 minutes) – The AI analyzes the clinical requirements to generate messaging that is both compelling to patients and compliant with regulatory standards. It simultaneously designs graphics, writes platform-specific copy, and produces fully mixed audio files.

Step 3: Review and Deploy (3 minutes) – The user previews the generated materials in a comprehensive toolkit. Minor adjustments can be made instantly before downloading the assets for immediate deployment across recruitment channels.

Significant Benefits for Clinical Research

The transition from traditional manual creation to AI-driven generation offers transformative advantages for the industry:

Speed to Enrollment: What once took 60-100 labor hours is now condensed into 10 minutes, allowing for same-day campaign launches and rapid enrollment acceleration.
Cost Efficiency: Eliminates the need for external creative vendors, music licensing fees, and expensive voice talent sessions. All tools are included within the TheraNovex platform.
Design Intelligence: The AI selects imagery and color schemes based on proven performance data for specific therapeutic areas, ensuring high engagement with target patient populations.
Scalability: Pharmaceutical sponsors can now launch recruitment across hundreds of sites with consistent, high-quality messaging, while small research sites can compete with larger networks by utilizing professional-grade marketing materials.

Compliance and Security

TheraNovex has prioritized regulatory integrity within the AI Agent’s core logic. The system is programmed to avoid overpromising or coercive language, and it automatically includes required disclosures, such as principal investigator credentials and HIPAA privacy statements. By standardizing regulatory language, the platform helps reduce IRB review times and provides a clear audit trail for all generated materials, ensuring that every asset meets the rigorous standards of clinical research advertising.

About TheraNovex

TheraNovex is a leading clinical trial patient recruitment company dedicated to accelerating medical innovation through technology. By combining advanced AI with deep clinical expertise, TheraNovex provides research sites, CROs, and sponsors with the tools necessary to reach the right patients at the right time, reducing the time and cost of bringing new therapies to market.